Universal Virtual Cell

A Universal Virtual Cell is a computer model that mimics a living cell so precisely that biological processes can be simulated within it. The goal is a single, universally applicable model – not dozens of specialized models for every cell type. It is meant to understand how genes are read, how proteins (the molecular machines of the cell) work, and how external influences change all of this. This makes it less a classic computer program and more an AI system that learns from vast amounts of biological measurement data. In essence, it’s about making the inner workings of the smallest unit of life – the cell – digitally comprehensible.

Significance for Medicine and Research

Anyone who wants to understand a disease must understand cells. Many diseases – including cancer, diabetes, or neurodegenerative conditions like Alzheimer’s – arise because something goes out of balance within individual cells. So far, potential drugs are tested in real cell cultures or animal experiments, which is expensive, slow, and ethically controversial.

A Universal Virtual Cell would shift this first step into the computer. One could test thousands of substances virtually and send only the most promising ones to the real lab. This saves not only time and money but also laboratory animals. For basic research, it also means hypotheses could be tested in a matter of seconds instead of waiting weeks for lab data.

How the Model Learns a Cell

The core is machine learning – a method in which a system recognizes patterns in data rather than being explicitly programmed. The model is trained on so-called omics data: genomics measures the genes, transcriptomics measures which genes are currently active, proteomics measures the proteins. From this interplay, the AI learns how a cell reacts to different situations.

This is harder than it sounds. A human cell contains around 20,000 genes and millions of protein molecules that constantly interact with one another. The model doesn’t need to copy this complexity exactly – it needs to predict it well enough to be useful. Current approaches, such as the one pursued by the Arc Institute project in the US, use architectures similar to those of large language models, but adapted to biological data.

A central challenge is generalization. A model that only knows liver cells is worthless for nerve cells. This is why “universal” becomes the actual technical challenge: the model should be able to transfer to cell types it has never seen during training – similar to how a good language model can also write texts on topics that rarely appeared in its training data.

Universal Virtual Cells in Current Products and News

The term appears mainly in research announcements from the bio-AI scene. In 2024 and 2025, several labs and start-ups announced they were working on such models – including the Arc Institute with its model “Evo” and various teams funded by the Chan Zuckerberg Initiative. Major tech companies like Google and Microsoft are also investing in related approaches such as AlphaFold, which predicts the structure of proteins.

The topic appears in financial news when pharmaceutical companies or biotech start-ups announce funding rounds centered on AI-driven drug development. The market for AI in drug research is estimated at several billion dollars and is growing rapidly. A functioning Universal Virtual Cell is considered one of the biggest potential breakthroughs – because it would accelerate nearly the entire early phase of drug development.

It’s important to distinguish this from digital twins, familiar from industry: a digital twin of a machine models physical processes according to known equations. A Virtual Cell, by contrast, learns its rules from data, because biology is too complex to be fully captured in formulas. This makes it more powerful – but also harder to verify.